Skip to main content
Livermore
Livermore
ZHEN

GAM Holding AG

SEC CIK
0001438848
Latest filing
Aug 14, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by GAM Holding AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
10,376
Value
$5.15M
% of portfolio
0.4%
Quarters held
21
Since Q1 2021
Holdings of VRTX by GAM Holding AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202610,376$5.15M0.4%+4,796+85.9%AddedHolders
Q1 20265,580$2.49M0.2%−3,972−41.6%ReducedHolders
Q4 20259,552$4.33M0.3%−1,463−13.3%ReducedHolders
Q3 202511,015$4.31M0.3%+462+4.4%AddedHolders
Q2 202510,553$4.70M0.3%−492−4.5%ReducedHolders
Q1 202511,045$5.35M0.4%+988+9.8%AddedHolders
Q4 202410,057$4.05M0.3%−234−2.3%ReducedHolders
Q3 202410,291$4.79M0.4%+1,381+15.5%AddedHolders
Q2 20248,910$4.18M0.3%−1,406−13.6%ReducedHolders
Q1 202410,316$4.31M0.3%+10+0.1%AddedHolders
Q4 202310,306$4.19M0.3%+2,979+40.7%AddedHolders
Q3 20237,327$2.55M0.2%+20.0%AddedHolders
Q2 20237,325$2.58M0.2%−12−0.2%ReducedHolders
Q1 20237,337$2.31M0.2%+428+6.2%AddedHolders
Q4 20226,909$2.00M0.2%+6,909NewHolders
Q3 20220$00.0%−6,160−100.0%Sold outHolders
Q2 20226,160$1.74M0.1%00.0%UnchangedHolders
Q1 20226,160$1.61M0.1%−10.0%ReducedHolders
Q4 20216,161$1.35M0.1%−1,074−14.8%ReducedHolders
Q3 20217,235$1.31M0.1%+10.0%AddedHolders
Q2 20217,234$1.46M0.1%−2,437−25.2%ReducedHolders
Q1 20219,671$2.08M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.